50% and the progenitor cell recovery 800%.
The transfusion of autologous cryopreserved bone marrow cells is a well established procedure in the management of both haematological and nonhaematological malignant diseases,1-3 though its precise role has yet to be defined. Before freezing harvested bone marrow it is desirable to reduce the total volume and this is achieved by removing erythrocytes, plasma and fat, with minimal loss of stem cells. Manipulation of allogeneic bone marrow in an attempt to ameliorate graft versus host disease also requires similar volume reduction. In the present paper three "closed" methods of processing bulk marrow are compared and the myeloid colonyforming assay is used to estimate the stem cell content, before and after processing. The method of freezing and thawing is described and the nucleated cell and progenitor cell recoveries after freezing and thawing are reported.
Patients and methods

PATIENTS
Marrow processing by various techniques was compared in 21 consecutive patients who were either in remission from acute leukaemia or had small cell carcinoma of the bronchus. Nucleated cell and progenitor cell recoveries after freezing and thawing are reported in 12 cases. Accepted for publication 6 transfer set (FPC 2240) and three-way tap using a 50 ml disposable syringe. This addition was performed under a 10 minute period, with good mixing to minimise osmotic shock. This procedure was performed on ice in a laminar flow sterile hood. Equal volumes (100-150 ml) of the processed marrow and cryopreservative were then transferred via a second AE2 transfer set attached to the three-way tap into four 700 ml Gambro Hemofreeze bags (DF-700-3). Ten to twenty millilitres were also placed in 2 ml freezing vials to enable repeated evaluation of the freezing and storage. Previous studies with peripheral blood leucocytes from patients with chronic granulocytic leukaemia showed that the progenitor cell recovery from both the 2 ml vial and the 120 ml bag were very similar when both were frozen at the same time. (vol/vol) in the final culture medium has no effect on CFU-GM growth (DC Linch, unpublished observations).
Results
MARROW PROCESSING
The average cell recoveries after processing by double centrifugation and by the Hemonetics cell separator are shown in Table 1 . There is no significant difference between the means of the cell populations processed by the two methods, but the ranges of the volume and red cell recoveries are considerably wider in those samples processed by double centrifugation. In both instances the percentage recovery of CFU-GM is greater than that of total nucleated cells. In six patients a direct comparison of the two methods of processing was made and the detailed results are shown in Table 2 . In these six experiments, the final volume was significantly less in the Hemonetics processed samples (p < 0-05) as was the red cell recovery (p < 0-01). The total nucleated cell yields and the CFU-GM recovery were similar by both methods. Review of the differential counts of the processed samples showed preferential loss of more mature myeloid and erythroid cells in only some cases, and this was always minor. No difference Range is indicated in parentheses. (Table 3) . Granulocytes and metamyelocytes were particularly sensitive to the freezing and thawing procedure. The progenitor cell recovery was significantly greater at 79 %. The method of marrow processing had no effect on the cell recoveries after freezing and thawing. Similar progenitor cell recoveries were found in the freezing bag (assessed at reinfusion) and in the freezing vials and no deterioration during storage was detected.
Discussion
The minimal number of marrow cells and CFU-GM required for autologous marrow engraftment is unknown, but is probably less than for allogeneic transplantation.10 11 Optimal processing of bone marrow prior to freezing is important, however, because this will enable smaller volumes to be harvested and will enable serial ablative chemotherapy to be performed12 by using only part of the cryopreserved marrow for each rescue procedure. It is possible to store whole, unprocessed bone Hemonetics cell separator, which is considerably less than our figure of 75 % obtained using a paediatric pheresis bowl. They stated that the differential count changed significantly after such processing with a rise in mononuclear cell count; no CFU-GM data was reported. We did not observe a significant change in the differential count, but the average CFU-GM yield (88 %) was greater than the total nucleated cell yield. The final volume after processing was also more variable, with double centrifugation. With the Hemonetics method, processing was continued to a predetermined volume. This was not always possible after the second manual centrifugation step, because leucocyte aggregates would sometimes form in the creases of the centrifuged transfer pack, and if these broke free during the plasma extraction, then this process had to be halted. Most of the cells in these aggregates were platelets, but some other cells were also present, and as CFU-GM are among the most buoyant of all marrow cells it was thought inadvisable to lose any large aggregates. The variable final volume after processing is a considerable problem with the manual centrifugation method, because all the freezing bags must contain the same volume to ensure equal cooling rates in the programmed freezer and if precise predictable cooling rates are to be achieved then the same freezing bag volumes must be used with each freezing procedure. We have aimed at a final marrow volume of 250 ml. When mixed with an equal volume of 20% (vol/vol) DMSO in TC 199, this allows four 120 ml aliquots to be put into freezing bags, and leaves sufficient marrow for cell culture studies and for freezing in 2 ml aliquots. These 2 ml aliquots can be used as guides to the freezing and storage efficiency.
The Aminco Celltrifuge gave disappointing results, due to drifting of the white cell layer. A deviation of the cell plasma interface away from the collection port by just one millimetre was sufficient to reduce the nucleated count in the collection port from 100 x 109/l to 18 x 109/l. Manual adjustment of the red cell and plasma pump rates brought the interface back into position, but no clear buffy coat was visible on marrow separation making this difficult. The buffy coat was not readily discernible because, unlike the procedure for collection of granulocytes, no sedimenting agent was used. We have not used sedimenting agents as preliminary experiments suggested that cell clumping increased after thawing if a sedimenting agent was present.
The average progenitor cell recovery of 79 % after freezing and thawing compares favourably with that reported by Wells.7 The nucleated cell recovery, however, was less than that seen by Wells (approximately 85 %), and this is because they had previously removed the thermally fragile granulocytic cells on a Ficoll-hypaque gradient. The lowest CFU-GM recovery seen was 30 % which still leaves a large safety margin in the autologous bone marrow transplant situation.
In conclusion, the Hemonetics model 30 cell separator with a paediatric pheresis bowl was found to be the optimal method of processing bone marrow prior to cryopreservation. Programmed freezing
